Bouvel Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Sell |
41,974
-1,908
| -4% | -$22.2K | 0.17% | 72 |
|
|
2025
Q1 | $225K | Buy |
43,882
+77
| +0.2% | +$394 | 0.08% | 77 |
|
|
2024
Q4 | $263K | Sell |
43,805
-77
| -0.2% | -$462 | 0.09% | 76 |
|
|
2024
Q3 | $225K | Sell |
43,882
-1,998
| -4% | -$10.2K | 0.08% | 77 |
|
|
2024
Q2 | $166K | Sell |
45,880
-150
| -0.3% | -$543 | 0.06% | 77 |
|
|
2024
Q1 | $148K | Buy |
46,030
+830
| +2% | +$2.66K | 0.06% | 75 |
|
|
2023
Q4 | $221K | Buy |
45,200
+1,001
| +2% | +$4.91K | 0.1% | 77 |
|
|
2023
Q3 | $241K | Buy |
44,199
+376
| +0.9% | +$2.05K | 0.13% | 77 |
|
|
2023
Q2 | $294K | Buy |
43,823
+1,391
| +3% | +$9.33K | 0.16% | 71 |
|
|
2023
Q1 | $375K | Buy |
42,432
+1,240
| +3% | +$10.9K | 0.22% | 68 |
|
|
2022
Q4 | $315K | Buy |
41,192
+1,534
| +4% | +$11.7K | 0.2% | 66 |
|
|
2022
Q3 | $282K | Buy |
39,658
+25,158
| +174% | +$179K | 0.19% | 66 |
|
|
2022
Q2 | $117K | Buy |
14,500
+113
| +0.8% | +$912 | 0.09% | 66 |
|
|
2022
Q1 | $200K | Buy |
14,387
+90
| +0.6% | +$1.25K | 0.12% | 65 |
|
|
2021
Q4 | $401K | Sell |
14,297
-173
| -1% | -$4.85K | 0.22% | 64 |
|
|
2021
Q3 | $492K | Sell |
14,470
-241
| -2% | -$8.19K | 0.28% | 64 |
|
|
2021
Q2 | $601K | Buy |
14,711
+75
| +0.5% | +$3.06K | 0.34% | 62 |
|
|
2021
Q1 | $589K | Sell |
14,636
-47
| -0.3% | -$1.89K | 0.38% | 59 |
|
|
2020
Q4 | $868K | Buy |
+14,683
| New | +$868K | 0.62% | 57 |
|